Fate Therapeutics | 10-Q: Quarterly report

Futu News04:09 · Announcements

Earnings Flash (FATE) FATE THERAPEUTICS Reports Q1 Revenue $1.9M

04:07 PM EDT, 05/09/2024 (MT Newswires) -- Earnings Flash (FATE) FATE THERAPEUTICS Reports Q1 Revenue $1.9M

MT Newswires04:07

Fate Therapeutics 1Q Loss/Shr 47c >FATE

Fate Therapeutics 1Q Loss/Shr 47c >FATE

Dow Jones04:01

Press Release: Fate Therapeutics Reports First Quarter 2024 Financial Results and Business Updates

Fate Therapeutics Reports First Quarter 2024 Financial Results and Business Updates First Lupus Patient Treated with FT819 CAR T-cell Product Candidate in Phase 1 Autoimmunity Study; Future Clinical

Dow Jones04:01

Fate Therapeutics Advances in Autoimmune and Cancer Therapies

TipRanksMay 9 21:12

Fate Therapeutics Treats First Lupus Patient In Phase 1 Study Of FT819 CAR T-Cell Therapy

Fate Therapeutics Treats First Lupus Patient In Phase 1 Study Of FT819 CAR T-Cell Therapy

BenzingaMay 9 20:33